Glenmark Pharma Q2 Results: Co posts Rs 355 crore net profit on robust sales growth

Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.